Flashcards in BB LEC - ABO Blood System Part 2 Deck (41)
reagent not used in routine ABO testing of donors and recipients but is used to resolve ABO typing problems
Resolves ABO typing problems when A2 phenotypes develop anti-A1
grade reaction of A1 and A2 phenotypes with commercial Anti-A reagents
3+ to 4+
B subgroups with only H substances in saliva
Bx and Bel
B subgroups with no B transferase in serum
Bx and Bel
unexpected antibody of this B subgroup is Anti-B
A and B specificity demonstrated only by ___
immunohematologic technique that uses red cells (known antigens) to remove red cell antibodies from a solution (plasma or antisera); group A red cells can remove anti-A from solution.
process that dissociates antigen-antibody complexes on red cells; freed IgG antibody is tested for specificity.
recessive allele of the ABO blood group system
Non–red blood cell stimulated: immunologic stimulus for antibody production is unrelated to a red cell antigen
Non–red blood cell stimulated:
Ig forms of Anti-A and Anti-B capable of activation and binding of complement and eventual hemolysis of red cells
IgG and IgM
genetic disease characterized by reduced levels of gamma globulin in the blood.
lower than normal levels of gamma globulin in the blood associated with malignant diseases (chronic leukemias and myeloma) and immunosuppressive therapy.
genetic disease characterized by the absence of gamma globulin and antibodies in the blood.
absence of gamma globulin and antibodies associated with malignant diseases such as leukemia, myeloma, or lymphoma.
WHICH AB react in immediate-spin phases
Anti-A and Anti-B
Activity of human anti-??? is regarded as a specificity that is cross-reactive with both A and B antigens.
A ____ is capable of recognizing a particular molecular structure (antigenic determi- nant) common to several molecules.
Human ___ also manifests the property of agglutinating red cells of infrequent subgroups of A, particularly Ax.
___ does not exist because the A2 phenotype possesses the same A antigens as A1 phenotype but in reduced quantities.
is not required for confirmatory testing of labeled, previously typed donor RBCs and in infants younger than 4 months
￼Reverse grouping (serum or plasma testing)
T or F
Neither human anti-A,B nor the monoclonal blend anti-A,B is required in ABO typing
ABO discrepancies that affect the testing of red cells (forward grouping) can be classified into three categories:
extra antigens present, missing or weak antigens, and mixed-field reactions.
Observations that denote discrepancies
weaker agglutination strengths
missing expected reactions
group A1 individual with disease of the lower gastrointestinal tract, cancer of the colon and rectum, intestinal obstruction, or gram-negative septicemia who acquires reactivity with anti-B reagents in ABO
red cell testing and appears as group AB.
Group A with acquired B antigen:
group B individual who acquires reactivity with anti-A reagents in ABO red cell testing; in these individuals, the B gene transfers trace amounts of the immunodominant sugar for the A antigen and the immunodominant sugar for the B antigen.
of cells that causes them to
be agglutinated by naturally
occurring antibodies found in
most human sera; agglutination
occurs regardless of blood type.
gelatinous tissue contaminant in cord blood samples that may interfere in immunohematologic tests.